Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
R1 RCM is a health information services business based in the US. R1 RCM stocks (RCM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $22.3 – a decrease of 2.42% over the previous week. R1 RCM employs 20,800 staff and has a trailing 12-month revenue of around $1.6 billion.
Finder's Pick for
Beginners
Finder's Pick for
Global Trading
Finder's Pick for
Free Trades
| Latest market close | $25.78 |
|---|---|
| 52-week range | $18.71 - $27.86 |
| 50-day moving average | $22.35 |
| 200-day moving average | $23.80 |
| Wall St. target price | $30.60 |
| PE ratio | 43.3115 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.61 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $25.78 from 2022-08-12
| 1 week (2022-08-05) | -2.42% |
|---|---|
| 1 month (2022-07-14) | 17.13% |
| 3 months (2022-05-13) | 14.48% |
| 6 months (2022-02-14) | 2.02% |
| 1 year (2021-08-13) | 27.62% |
|---|---|
| 2 years (2020-08-14) | 71.41% |
| 3 years (2019-08-14) | 114.48% |
| 5 years (2017-08-11) | 737.01% |
Valuing R1 RCM stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of R1 RCM's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
R1 RCM's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, R1 RCM shares trade at around 43x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
R1 RCM's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.994. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into R1 RCM's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
R1 RCM's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $297.1 million.
The EBITDA is a measure of a R1 RCM's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.6 billion |
|---|---|
| Operating margin TTM | 13.59% |
| Gross profit TTM | $311.8 million |
| Return on assets TTM | 4.22% |
| Return on equity TTM | 4.03% |
| Profit margin | 3.98% |
| Book value | $6.61 |
| Market capitalisation | $7.4 billion |
TTM: trailing 12 months
We're not expecting R1 RCM to pay a dividend over the next 12 months.
R1 RCM's shares were split on 22 June 2022.
Over the last 12 months, R1 RCM's shares have ranged in value from as little as $18.71 up to $27.86. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while R1 RCM's is 0.9093. This would suggest that R1 RCM's shares are less volatile than average (for this exchange).
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah. .
You can’t buy NFL stock directly, but you can invest in companies that back the football industry.
Read more…
Compare 15 of the best stock picking services, and learn how to choose the best option for your needs.
Read more…
Here are the best Canadian investment newsletters to help you boost your investment knowledge and grow your wealth.
Read more…Everything we know about the GigaCloud Technology Inc. IPO plus information on how to buy in.
Everything we know about the Starbox Group Holdings Ltd. IPO plus information on how to buy in.
Steps to owning and managing MEGL stock, with 24-hour and historical pricing before you buy.
Steps to owning and managing QS stock, with 24-hour and historical pricing before you buy.
Everything we know about the Bruush Oral Care IPO plus information on how to buy in.
Everything we know about the Loop Media IPO plus information on how to buy in.
Are you looking to start stock trading? Here’s our top 7 tips to help you begin.
Everything we know about the Savage X Fenty IPO plus information on how to buy in.
Find out the key differences between the FTSE 100 and the S&P 500.
Everything we know about the DeLorean Motor Company IPO plus information on how to buy in.
